Clinical Research Skills Development Program in Cell-Based Regenerative Medicine

被引:9
|
作者
Schulman, Ivonne Hernandez [1 ,2 ]
Suncion, Viky [1 ]
Karantalis, Vasileios [1 ]
Balkan, Wayne [1 ]
Hare, Joshua M. [1 ]
机构
[1] Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL 33136 USA
[2] Univ Miami, Miller Sch Med, Div Nephrol & Hypertens, Miami, FL 33136 USA
关键词
MESENCHYMAL STEM-CELLS; TRANSENDOCARDIAL INJECTION; ISCHEMIC CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; TISSUE PERFUSION; THERAPY; NETWORK; DELIVERY; EUROPE; TRIALS;
D O I
10.5966/sctm.2014-0144
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Cell-based therapy aimed at restoring organ function is one of the most exciting and promising areas of medical research. However, a novel intervention like cell-based therapy requires physician education and training. An increasing number of physicians untrained in regenerative medicine are using cell-based therapy to treat patients for a wide variety of chronic illnesses. The current lack of training for physicians in this area combined with the sharply increasing practice of regenerative medicine is concerning for a number of reasons, namely potential harm to patients and avoidable conflicts between governmental regulatory agencies and physicians. Academic medical fellowship training programs are needed that specifically prepare physicians for treating patients with cell-based therapies for various organ systems and chronic diseases. The National Heart, Lung, and Blood Institute established the Cardiovascular Cell Therapy Network to design and conduct clinical trials that advance the field of cell-based therapy for patients with cardiovascular disease. As part of the network, a two-year Clinical Research Skills Development Program was supported at two centers with the goal of training early career investigators in cell-based clinical and translational research. In this review, we describe the implementation of this training program at our institution with the purpose of promoting the further development of academic fellowship programs in cell-based regenerative medicine.
引用
收藏
页码:118 / 122
页数:5
相关论文
共 50 条
  • [11] The role of biomaterials in stem cell-based regenerative medicine
    Zhao, Xiangnan
    Cui, Kaige
    Li, Zongjin
    FUTURE MEDICINAL CHEMISTRY, 2019, 11 (14) : 1777 - 1790
  • [12] Shire punts on bioscaffolds for cell-based regenerative medicine
    Mark Ratner
    Nature Biotechnology, 2012, 30 : 727 - 728
  • [13] Shire punts on bioscaffolds for cell-based regenerative medicine
    Ratner, Mark
    NATURE BIOTECHNOLOGY, 2012, 30 (08) : 727 - 728
  • [14] Nanotechnology-Driven Cell-Based Therapies in Regenerative Medicine
    Alzate-Correa, D.
    Lawrence, W. R.
    Salazar-Puerta, A.
    Higuita-Castro, N.
    Gallego-Perez, D.
    AAPS JOURNAL, 2022, 24 (02):
  • [15] Stem cell-based composite tissue constructs for regenerative medicine
    Rahaman, MN
    Mao, JJ
    BIOTECHNOLOGY AND BIOENGINEERING, 2005, 91 (03) : 261 - 284
  • [16] Regenerative medicine and cell-based approaches to restore pancreatic function
    Cara Ellis
    Adam Ramzy
    Timothy J. Kieffer
    Nature Reviews Gastroenterology & Hepatology, 2017, 14 : 612 - 628
  • [17] Nanotechnology-Driven Cell-Based Therapies in Regenerative Medicine
    D. Alzate-Correa
    W. R. Lawrence
    A. Salazar-Puerta
    N. Higuita-Castro
    D. Gallego-Perez
    The AAPS Journal, 24
  • [18] The application of resveratrol to mesenchymal stromal cell-based regenerative medicine
    Hu, Chenxia
    Li, Lanjuan
    STEM CELL RESEARCH & THERAPY, 2019, 10 (01)
  • [19] Biomaterials as carrier, barrier and reactor for cell-based regenerative medicine
    Qi, Chunxiao
    Yan, Xiaojun
    Huang, Chenyu
    Melerzanov, Alexander
    Du, Yanan
    PROTEIN & CELL, 2015, 6 (09) : 638 - 653
  • [20] Mesenchymal stem cell-based nanoparticles and scaffolds in regenerative medicine
    Raghav, Pawan Kumar
    Mann, Zoya
    Ahlawat, Swati
    Mohanty, Sujata
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 918